The 19 analysts offering 12-month price forecasts for Abbott Laboratories have a median target of 138.00, with a high estimate of 146.00 and a low estimate of 109.00. The median estimate represents a +10.36% increase from the last price of 125.04.
The current consensus among 25 polled investment analysts is to Buy stock in Abbott Laboratories. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.12
Reporting Date Jan 26
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.